| |
| |
|
| Insider
Information: |
Mario Ernest |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
1,089,697 |
|
|
Indirect Shares
|
264,473 |
|
|
| Direct
Value |
$8,174,223 |
|
|
|
Indirect Value
|
$107,705 |
|
|
| Total
Shares |
1,354,170 |
|
|
| Total
Value |
$8,281,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -41.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
Director |
2024-01-08 |
124,566 |
2024-01-08 |
20,752 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2024-01-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,523 |
124,566 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2023-11-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,700 |
128,089 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
I/I |
930,000 |
930,000 |
2.02 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
D/D |
930,000 |
2,363,135 |
2.31 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2022-01-31 |
4 |
A |
$0.36 |
$20,000 |
D/D |
56,338 |
1,433,135 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2021-10-29 |
4 |
A |
$0.00 |
$0 |
D/D |
26,888 |
1,376,797 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2021-07-30 |
4 |
A |
$0.91 |
$20,000 |
D/D |
21,978 |
1,349,909 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2021-04-30 |
4 |
A |
$1.21 |
$20,000 |
D/D |
16,529 |
1,176,416 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
8,928 |
1,157,804 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2021-01-15 |
4 |
OE |
$2.27 |
$93,560 |
D/D |
41,216 |
375,743 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2020-10-30 |
4 |
A |
$1.74 |
$17,499 |
D/D |
10,057 |
1,148,876 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2020-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,288 |
334,527 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2020-07-31 |
4 |
A |
$1.72 |
$17,499 |
D/D |
10,174 |
10,174 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2020-04-30 |
4 |
A |
$3.05 |
$17,501 |
D/D |
5,738 |
5,738 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2020-03-24 |
4 |
B |
$2.27 |
$187,118 |
D/D |
82,431 |
327,239 |
2.39 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2020-01-22 |
4 |
A |
$3.35 |
$35,001 |
D/D |
10,448 |
10,448 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,908) |
0 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(62,884) |
0 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2019-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,038 |
280,779 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2019-07-11 |
4 |
B |
$2.78 |
$99,999 |
D/D |
35,971 |
272,741 |
2.39 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
375 |
62,884 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
300 |
62,509 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
484 |
62,209 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-03-05 |
4 |
A |
$85.97 |
$250,001 |
I/I |
2,908 |
4,908 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-03-05 |
4 |
D |
$85.97 |
$250,001 |
D/D |
(2,908) |
55,005 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
